Turbulence Activates Platelet Biogenesis to Enable Clinical Scale Ex Vivo Production
The ex vivo generation of platelets from human-induced pluripotent cells (hiPSCs) is expected to compensate donor-dependent transfusion systems. However, manufacturing the clinically required number of platelets remains unachieved due to the low platelet release from hiPSC-derived megakaryocytes (hi...
Saved in:
Published in | Cell Vol. 174; no. 3; pp. 636 - 648.e18 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
26.07.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!